411 related articles for article (PubMed ID: 9157987)
1. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
Kirichenko AV; Rich TA; Newman RA; Travis EL
Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
[TBL] [Abstract][Full Text] [Related]
3. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054
[TBL] [Abstract][Full Text] [Related]
4. Radiation enhancement by 9-aminocamptothecin: the effect of fractionation and timing of administration.
Kirichenko AV; Rich TA
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):659-64. PubMed ID: 10348297
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel enhances tumor radioresponse in vivo.
Mason KA; Hunter NR; Milas M; Abbruzzese JL; Milas L
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2431-8. PubMed ID: 9815644
[TBL] [Abstract][Full Text] [Related]
6. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
7. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
[TBL] [Abstract][Full Text] [Related]
8. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
Sun LQ; Li YX; Guillou L; Coucke PA
Cancer Res; 1998 Dec; 58(23):5411-7. PubMed ID: 9850073
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
Milas L; Hunter NR; Mason KA; Kurdoglu B; Peters LJ
Cancer Res; 1994 Jul; 54(13):3506-10. PubMed ID: 7912167
[TBL] [Abstract][Full Text] [Related]
10. Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity.
Vujaskovic Z; Feng QF; Rabbani ZN; Samulski TV; Anscher MS; Brizel DM
Exp Lung Res; 2002; 28(7):577-90. PubMed ID: 12396250
[TBL] [Abstract][Full Text] [Related]
12. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].
Mukai M; Ando K; Koike S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184
[TBL] [Abstract][Full Text] [Related]
13. 9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancer.
de Souza PL; Cooper MR; Imondi AR; Myers CE
Clin Cancer Res; 1997 Feb; 3(2):287-94. PubMed ID: 9815685
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
15. Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo.
Tian J; Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):230-6. PubMed ID: 20615620
[TBL] [Abstract][Full Text] [Related]
16. Experimental studies on the radiation-modifying effect of bleomycin in malignant and normal mouse tissue in vivo.
Molin J; Søgaard PE; Overgaard J
Cancer Treat Rep; 1981; 65(7-8):583-9. PubMed ID: 6166372
[TBL] [Abstract][Full Text] [Related]
17. Maximizing therapeutic gain with gemcitabine and fractionated radiation.
Mason KA; Milas L; Hunter NR; Elshaikh M; Buchmiller L; Kishi K; Hittelman K; Ang KK
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1125-35. PubMed ID: 10421547
[TBL] [Abstract][Full Text] [Related]
18. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
19. Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice.
Dexter DL; Lee ES; Bliven SF; Glicksman AS; Leith JT
Cancer Res; 1984 Nov; 44(11):4942-6. PubMed ID: 6488157
[TBL] [Abstract][Full Text] [Related]
20. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
Murata R; Tsujitani M; Horsman MR
Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
